Arginine-dependent immune responses
A growing body of evidence indicates that, over the course of evolution of the immune system, arginine has been selected as a node for the regulation of immune responses. An appropriate supply of arginine has long been associated with the improvement of immune responses. In addition to being a build...
Saved in:
Published in | Cellular and molecular life sciences : CMLS Vol. 78; no. 13; pp. 5303 - 5324 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.07.2021
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 1420-682X 1420-9071 1420-9071 |
DOI | 10.1007/s00018-021-03828-4 |
Cover
Summary: | A growing body of evidence indicates that, over the course of evolution of the immune system, arginine has been selected as a node for the regulation of immune responses. An appropriate supply of arginine has long been associated with the improvement of immune responses. In addition to being a building block for protein synthesis, arginine serves as a substrate for distinct metabolic pathways that profoundly affect immune cell biology; especially macrophage, dendritic cell and T cell immunobiology. Arginine availability, synthesis, and catabolism are highly interrelated aspects of immune responses and their fine-tuning can dictate divergent pro-inflammatory or anti-inflammatory immune outcomes. Here, we review the organismal pathways of arginine metabolism in humans and rodents, as essential modulators of the availability of this semi-essential amino acid for immune cells. We subsequently review well-established and novel findings on the functional impact of arginine biosynthetic and catabolic pathways on the main immune cell lineages. Finally, as arginine has emerged as a molecule impacting on a plethora of immune functions, we integrate key notions on how the disruption or perversion of arginine metabolism is implicated in pathologies ranging from infectious diseases to autoimmunity and cancer. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ISSN: | 1420-682X 1420-9071 1420-9071 |
DOI: | 10.1007/s00018-021-03828-4 |